España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Zelira Therapeutics
ZLDAF
OTCQB
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.3547
Last update: Dec 31, 7:00 PM
Get Report
Comment
Zelira Therapeutics (ZLDAF) Forecast
News
Earnings
Zelira Therapeutics (ZLDAF) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Zelira Therapeutics (OTC:ZLDAF) Stock
Zelira Therapeutics Stock (OTC: ZLDAF)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, January 15, 2025
FDA Solicits Public Comments On Use Of Cannab...
Benzinga Newsdesk
Wednesday, January 01, 2025
Bullish Wednesday For Marijuana Stocks - Cara Therapeutics, MPX International Among Top Gainers
Benzinga Insights
Wednesday, December 25, 2024
Marijuana Stock Movers For December 25, 2024
Benzinga Insights
Tuesday, December 24, 2024
Cannabis Stock Gainers And Losers From December 24, 2024
Benzinga Insights
Wednesday, December 11, 2024
Dropbox shares are trading higher after the c...
Benzinga Newsdesk
Wednesday, November 06, 2024
AP Reports Florida Voters Reject Cannabis Leg...
Benzinga Newsdesk
Wednesday, October 30, 2024
Microsoft shares are trading higher after the...
Benzinga Newsdesk
Tuesday, October 08, 2024
Bullish Sentiment Across The Cannabis Space - Check Full Movers For October 8, 2024
Benzinga Insights
Monday, October 07, 2024
Marijuana Stock Movers For October 7, 2024
Benzinga Insights
Wednesday, August 21, 2024
Cannabis Stock Movers For August 21, 2024
Benzinga Insights
Monday, August 05, 2024
Cannabis Stock Gainers And Losers From August 5, 2024
Benzinga Insights
Friday, August 02, 2024
Marijuana Stock Movers For August 2, 2024
Benzinga Insights
Thursday, August 01, 2024
Cannabis Stock Movers For August 1, 2024
Benzinga Insights
Monday, July 15, 2024
Cannabis Stock Gainers And Losers From July 15, 2024
Benzinga Insights
Friday, July 12, 2024
Cannabis Stock Movers For July 12, 2024
Benzinga Insights
Monday, July 08, 2024
Cannabis Stock Movers For July 8, 2024
Benzinga Insights
Thursday, July 04, 2024
Marijuana Stock Movers For July 4, 2024
Benzinga Insights
Wednesday, July 03, 2024
Cannabis Stock Gainers And Losers From July 3, 2024
Benzinga Insights
Tuesday, June 25, 2024
Bearish Sentiment Across The Cannabis Space - Check Full Movers For June 25, 2024
Benzinga Insights
Tuesday, June 11, 2024
Cannabis Stock Gainers And Losers From June 11, 2024
Benzinga Insights
Monday, May 27, 2024
Bearish Sentiment Across The Cannabis Space - Check Full Movers For May 27, 2024
Benzinga Insights
Friday, May 24, 2024
Cannabis Stock Movers For May 24, 2024
Benzinga Insights
Wednesday, May 08, 2024
Cannabis Stock Movers For May 8, 2024
Benzinga Insights
Wednesday, April 03, 2024
Cannabis Stock Movers For April 3, 2024
Benzinga Insights
Monday, March 04, 2024
Cannabis Stock Gainers And Losers From March 4, 2024
Benzinga Insights
Monday, January 22, 2024
Cannabis Stock Movers For January 22, 2024
Benzinga Insights
Friday, January 05, 2024
Bullish Friday For Marijuana Stocks - Choom Holdings, EVIO Among Top Gainers
Benzinga Insights
Friday, December 15, 2023
Bearish Friday For Marijuana Stocks - GreenGro Technologies, Body and Mind Among Top Gainers
Benzinga Insights
Monday, November 27, 2023
Cannabis Stock Movers For November 27, 2023
Benzinga Insights
Thursday, November 16, 2023
Bullish Thursday For Marijuana Stocks - MPX International, GrowLife Among Top Gainers
Benzinga Insights
Wednesday, November 15, 2023
Cannabis Stock Gainers And Losers From November 15, 2023
Benzinga Insights
Monday, October 16, 2023
Marijuana Stock Movers For October 16, 2023
Benzinga Insights
Thursday, October 12, 2023
Cannabis Stock Movers For October 12, 2023
Benzinga Insights
Tuesday, September 26, 2023
Bearish Sentiment Across The Cannabis Space - Check Full Movers For September 26, 2023
Benzinga Insights
Wednesday, September 20, 2023
Cannabis Stock Gainers And Losers From September 20, 2023
Benzinga Insights
Tuesday, August 15, 2023
Marijuana Stock Movers For August 15, 2023
Benzinga Insights
Thursday, August 10, 2023
Cannabis Stock Movers For August 10, 2023
Benzinga Insights
Wednesday, August 09, 2023
Marijuana Stock Movers For August 9, 2023
Benzinga Insights
Tuesday, August 08, 2023
Marijuana Stock Movers For August 8, 2023
Benzinga Insights
Monday, August 07, 2023
Bearish Monday For Marijuana Stocks - EVIO, Item 9 Labs Among Top Gainers
Benzinga Insights
Friday, July 28, 2023
Cannabis Stock Gainers And Losers From July 28, 2023
Benzinga Insights
Wednesday, July 26, 2023
Cannabis Stock Gainers And Losers From July 26, 2023
Benzinga Insights
Wednesday, July 19, 2023
Cannabis Stock Movers For July 19, 2023
Benzinga Insights
Wednesday, May 31, 2023
This Cannabis-Based Drug Has Outperformed Pfizer's Lyrica In Clinical Trials: A New Dawn For Diabetic Nerve Pain Management?
Javier Hasse
Wednesday, February 15, 2023
Medical Cannabis For Autism: Zelira Receives $8.6M For FDA Clinical Trials For Treatment
Joana Scopel
Wednesday, November 09, 2022
A Global List Of Cannabis Operators And Executives To Keep An Eye On In 2022 And Beyond
Javier Hasse
Monday, August 15, 2022
Sun, Water, Weed And B2B?: What Opportunities Can Cannabis Investors Expect From This Conference In Panama
El Planteo
Friday, July 22, 2022
Zelira's Zenivol, Clinically Validated Cannabinoid Medication For Insomnia, Gets Regulatory Approval In Germany
Vuk Zdinjak
Monday, June 27, 2022
The Best Cannabis Conference In Latin America Arrives In Panama: Join LATAM CANN.BIZ On Sep. 1 & 2, Get Business Done
Benzinga Cannabis
Thursday, June 09, 2022
Cannabis Goes Head-to-Head With Big Pharma In New Zelira Therapeutics Pain Med Study
Maureen Meehan
Show More
